Search Orphan Drug Designations and Approvals
-
| Generic Name: | Purified Human Allogeneic Pancreatic Islets of Langerhans |
|---|---|
| Date Designated: | 03/09/2020 |
| Orphan Designation: | Treatment of Brittle Type 1 Diabetes |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
University of Minnesota 420 Delaware Street, S.E. MMC 195 Minneapolis, Minnesota 55455 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







